COVID-19: Analysis of Drug Repositioning Practice.

COVID-19 drug repositioning in vitro inhibition of SARS-CoV-2 replication

Journal

Pharmaceutical chemistry journal
ISSN: 0091-150X
Titre abrégé: Pharm Chem J
Pays: United States
ID NLM: 0323156

Informations de publication

Date de publication:
2021
Historique:
received: 14 09 2020
pubmed: 19 1 2021
medline: 19 1 2021
entrez: 18 1 2021
Statut: ppublish

Résumé

An outbreak of a new coronavirus disease (COVID-19) in China in December 2019 became the epicenter for the spread of a global pandemic. The SARS-CoV-2 coronavirus causes a cascade of respiratory diseases similar to severe acute respiratory syndrome (SARS). Currently, there is no effective, specific, and safe treatment for COVID-19 to suppress the virus in the human body. The present study searched for pharmacological substances with antiviral activity for possible drug repositioning based on experimental and theoretical information in a series of publications on

Identifiants

pubmed: 33456092
doi: 10.1007/s11094-021-02308-0
pii: 2308
pmc: PMC7797491
doi:

Types de publication

Journal Article

Langues

eng

Pagination

989-996

Informations de copyright

© Springer Science+Business Media, LLC, part of Springer Nature 2021.

Références

J Virol. 2020 Oct 14;94(21):
pubmed: 32817221
Antimicrob Agents Chemother. 2020 Jun 23;64(7):
pubmed: 32366720
Mayo Clin Proc. 2020 Jun;95(6):1296-1297
pubmed: 32402512
Cell Res. 2020 Mar;30(3):269-271
pubmed: 32020029
Antiviral Res. 2020 Jun;178:104787
pubmed: 32251768
Int J Antimicrob Agents. 2020 Aug;56(2):106028
pubmed: 32450198
Chest. 2020 Nov;158(5):2003-2006
pubmed: 32512007
Antimicrob Agents Chemother. 2020 May 21;64(6):
pubmed: 32312781
ACS Cent Sci. 2020 May 27;6(5):672-683
pubmed: 32483554
Antiviral Res. 2015 Mar;115:21-38
pubmed: 25554382
Virology. 2020 Aug;547:7-11
pubmed: 32442105
Pharmacol Res. 2020 Sep;159:104960
pubmed: 32473310
Science. 2020 Apr 24;368(6489):409-412
pubmed: 32198291
Science. 2020 May 15;368(6492):779-782
pubmed: 32277040
Transbound Emerg Dis. 2021 Mar;68(2):313-317
pubmed: 32619318
Sci Rep. 2020 Aug 4;10(1):13093
pubmed: 32753646
Int J Mol Sci. 2020 Apr 10;21(7):
pubmed: 32290293
Nature. 2020 Jul;583(7816):459-468
pubmed: 32353859

Auteurs

P I Savosina (PI)

V. N. Orekhovich Institute of Biomedical Chemistry, 10/7 Pogodinskaya St., Moscow, 119121 Russia.

D S Druzhilovskii (DS)

V. N. Orekhovich Institute of Biomedical Chemistry, 10/7 Pogodinskaya St., Moscow, 119121 Russia.

V V Poroikov (VV)

V. N. Orekhovich Institute of Biomedical Chemistry, 10/7 Pogodinskaya St., Moscow, 119121 Russia.

Classifications MeSH